156 related articles for article (PubMed ID: 9699531)
21. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast.
Beaty MW; Quezado M; Sobel ME; Duray P; Merino MJ
Int J Surg Pathol; 2005 Jan; 13(1):9-18. PubMed ID: 15735850
[TBL] [Abstract][Full Text] [Related]
22. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
[TBL] [Abstract][Full Text] [Related]
23. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity (LOH) in non-small cell lung cancer: difference between adenocarcinoma and squamous cell carcinoma.
Yoshino I; Osoegawa A; Yohena T; Kameyama T; Oki E; Oda S; Maehara Y
Respir Med; 2005 Mar; 99(3):308-12. PubMed ID: 15733506
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques.
Zhu W; Zou H; Beck A; Chervinsky D; Malik D; Brooks J; Tan D
Med Sci Monit; 2002 Mar; 8(3):BR95-9. PubMed ID: 11889456
[TBL] [Abstract][Full Text] [Related]
26. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer.
Tsuchiya E; Tanigami A; Ishikawa Y; Nishida K; Hayashi M; Tokuchi Y; Hashimoto T; Okumura S; Tsuchiya S; Nakagawa K
Jpn J Cancer Res; 2000 Jun; 91(6):589-96. PubMed ID: 10874210
[TBL] [Abstract][Full Text] [Related]
27. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
[TBL] [Abstract][Full Text] [Related]
28. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
29. Analysis of loss of heterozygosity in small adenocarcinomas of the lung.
Yoshioka H; Takeuchi T; Matsuno Y; Yamada T; Shimosato Y; Hirohashi S; Noguchi M
Jpn J Clin Oncol; 1998 Apr; 28(4):240-4. PubMed ID: 9657008
[TBL] [Abstract][Full Text] [Related]
30. High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.
Devlin J; Elder PA; Gabra H; Steel CM; Knowles MA
Br J Cancer; 1996 Feb; 73(4):420-3. PubMed ID: 8595153
[TBL] [Abstract][Full Text] [Related]
31. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas.
Herzog CR; Chen B; Wang Y; Schut HA; You M
Mol Carcinog; 1996 Jun; 16(2):83-90. PubMed ID: 8645430
[TBL] [Abstract][Full Text] [Related]
33. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix.
Kersemaekers AM; Hermans J; Fleuren GJ; van de Vijver MJ
Br J Cancer; 1998; 77(2):192-200. PubMed ID: 9460988
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
Acevedo CM; HenrĂquez M; Emmert-Buck MR; Chuaqui RF
Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
[TBL] [Abstract][Full Text] [Related]
37. Novel TSC2 mutation in a patient with pulmonary tuberous sclerosis: lack of loss of heterozygosity in a lung cyst.
Zhang H; Yamamoto T; Nanba E; Kitamura Y; Terada T; Akaboshi S; Yuasa I; Ohtani K; Nakamoto S; Takeshita K; Ohno K
Am J Med Genet; 1999 Feb; 82(5):368-70. PubMed ID: 10069705
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity on tuberous sclerosis complex genes in multifocal micronodular pneumocyte hyperplasia.
Hayashi T; Kumasaka T; Mitani K; Yao T; Suda K; Seyama K
Mod Pathol; 2010 Sep; 23(9):1251-60. PubMed ID: 20526286
[TBL] [Abstract][Full Text] [Related]
39. Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma.
Tsuchiya E; Nakamura Y; Weng SY; Nakagawa K; Tsuchiya S; Sugano H; Kitagawa T
Cancer Res; 1992 May; 52(9):2478-81. PubMed ID: 1314694
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]